These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2143669

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 24. [Update on paraneoplastic hypercalcemia. Our experience in the treatment of hypercalcemic states of patients with advanced breast carcinoma].
    Grottolo A, Ferrari V, Lazzari R, Mariano MR, Zambruni A, Zaniboni A.
    Minerva Med; 1988 Jul; 79(7):527-31. PubMed ID: 3405454
    [Abstract] [Full Text] [Related]

  • 25. Hypercalcemia in breast cancer.
    Razis DV, Petounis AC, Constantoulakis MM.
    J Med; 1981 Jul; 12(1):63-9. PubMed ID: 6943266
    [Abstract] [Full Text] [Related]

  • 26. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D, Plestina S, Belev B, Unusić J, Pavlinić-Diminić V.
    Lijec Vjesn; 1999 Jul; 121(9-10):296-301. PubMed ID: 19658372
    [Abstract] [Full Text] [Related]

  • 27. Oral bisphosphonates as adjuvant therapy for operable breast cancer.
    Powles T, McCroskey E, Paterson A.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6301s-6304s. PubMed ID: 17062718
    [Abstract] [Full Text] [Related]

  • 28. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E, Martodam RR, Troxell M, Benson A, Paterson A, Shepard K, Hicks R.
    Arch Intern Med; 1985 Mar 15; 145(3):449-52. PubMed ID: 3919667
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C, Racanelli A.
    Clin Ter; 1981 Aug 15; 98(3):247-67. PubMed ID: 7285537
    [No Abstract] [Full Text] [Related]

  • 31. Hypercalcemia: an evidence-based approach to clinical cases.
    Assadi F.
    Iran J Kidney Dis; 2009 Apr 15; 3(2):71-9. PubMed ID: 19395781
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Studies on the pathogenesis of cancer hypercalcemia.
    Laird Myers WP, Bockman R.
    Trans Am Clin Climatol Assoc; 1977 Apr 15; 88():177-90. PubMed ID: 898535
    [Abstract] [Full Text] [Related]

  • 34. Clinical practice. Hypercalcemia associated with cancer.
    Stewart AF.
    N Engl J Med; 2005 Jan 27; 352(4):373-9. PubMed ID: 15673803
    [No Abstract] [Full Text] [Related]

  • 35. Acute management of cancer-related hypercalcemia.
    Chisholm MA, Mulloy AL, Taylor AT.
    Ann Pharmacother; 1996 May 27; 30(5):507-13. PubMed ID: 8740333
    [Abstract] [Full Text] [Related]

  • 36. Treatment of cancer-related hypercalcemia.
    Ritch PS.
    Semin Oncol; 1990 Apr 27; 17(2 Suppl 5):26-33. PubMed ID: 2185550
    [Abstract] [Full Text] [Related]

  • 37. [Refractory hypercalcemia in patient with lung cancer].
    Grzywacz A, Dziuk M, Niemczyk S.
    Pol Merkur Lekarski; 2014 Apr 27; 36(214):261-4. PubMed ID: 24868900
    [Abstract] [Full Text] [Related]

  • 38. [Hypercalcemic crisis in intensive care].
    Haap M, Tschritter O, Artunc F, Rettig I, Riessen R.
    Dtsch Med Wochenschr; 2012 May 27; 137(21):1100-4. PubMed ID: 22588655
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hypercalcemia].
    Dylewska M, Wieliczko M.
    Wiad Lek; 2013 May 27; 66(4):307-10. PubMed ID: 24490483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.